Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live

Novo Nordisk & Sanofi

8 shared events · Importance 3 · Last updated Sep 22, 2026

Importance
3
Shared Events
8
Actions
0
Sentiment
0
Live sentiment trends, interaction importance charts, and action volume tracking available on the Ergen Dashboard
70
Regulatory
Novo Nordisk: One of the nine drugmakers signing the letter calling for greater EU investment in pharmaceuticals. The initiative reflects its interest in faster European clinical trials and improved market access.
Sanofi: A signatory of the open letter calling on the European Union to boost pharmaceutical investment. The appeal reflects its concern about Europe lagging the United States and China in drug research and trials.
Sep 22, 2026 · 6 articles
63
Business
Novo Nordisk: Novo Nordisk launched Awiqli, its once-weekly insulin, in India, enhancing its product portfolio and competitive edge in the diabetes market.
Sanofi: Sanofi's Lantus faces new competition from Awiqli, which offers less frequent dosing and lower cost per unit.
Jul 09, 2026 · 21 articles
22
Business
Novo Nordisk: Novo Nordisk is the central party, gaining access to Anthropic's Claude models and Claude Science to accelerate drug discovery and AI-driven software development. The deal supports its ambition to become the world's most AI-driven healthcare company and could improve R&D efficiency.
Sanofi: Sanofi is mentioned only through a quote from its chief digital officer about AI competitiveness, providing industry context rather than a direct role in the event.
Sep 16, 2026 · 20 articles
21
Tech
Novo Nordisk: Manufacturer of Saxenda and Wegovy; rising pediatric prescriptions could expand market.
Sanofi: Segev received honoraria; unrelated to study.
Sep 04, 2026 · 7 articles
20
Tech
Novo Nordisk: Novo Nordisk is a sponsor of World Hemophilia Day 2026, supporting the World Federation of Hemophilia's efforts.
Sanofi: Sanofi is a sponsor of World Hemophilia Day 2026, supporting the World Federation of Hemophilia's efforts.
Apr 17, 2026 · 6 articles
0
Regulatory
Dec 19, 2025 · 7 articles
0
Domestic
Sanofi: Sanofi is a major insulin maker that has moved to cut the cost of insulin and offers a savings program for people without health insurance.
Apr 02, 2026 · 6 articles
0
Business
May 08, 2026 · 6 articles
ERGEN INTELLIGENCE
Explore this relationship live

Track how Novo Nordisk and Sanofi interact across events, view sentiment trends, and discover connected entities.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.